Your browser doesn't support javascript.
loading
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-ß2GPI I domain.
Infantino, Maria; Foddai, Silvia; Manfredi, Mariangela; Benucci, Maurizio; Radin, Massimo; Cecchi, Irene; Barinotti, Alice; Aluf, Ofir; Rubini, Elena; Elnaz, Rahbari; Menegatti, Elisa; Roccatello, Dario; Sciascia, Savino.
Afiliación
  • Infantino M; Laboratory of Immunology and Allergology, S. Giovanni di Dio Hospital, Florence, Italy. Electronic address: maria2.infantino@uslcentro.toscana.it.
  • Foddai S; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont an
  • Manfredi M; Laboratory of Immunology and Allergology, S. Giovanni di Dio Hospital, Florence, Italy.
  • Benucci M; Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.
  • Radin M; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont an
  • Cecchi I; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont an
  • Barinotti A; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont an
  • Aluf O; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont an
  • Rubini E; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont an
  • Elnaz R; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont an
  • Menegatti E; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont an
  • Roccatello D; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont an
  • Sciascia S; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont an
Autoimmun Rev ; 22(11): 103454, 2023 11.
Article en En | MEDLINE | ID: mdl-37741530

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome Antifosfolípido / Anticuerpos Antifosfolípidos Idioma: En Revista: Autoimmun Rev Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome Antifosfolípido / Anticuerpos Antifosfolípidos Idioma: En Revista: Autoimmun Rev Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article